Deprecated: strripos(): Non-string needles will be interpreted as strings in the future. Use an explicit chr() call to preserve the current behavior in /home/customer/www/nysedojo.com/public_html/functions.php on line 772
XBIO
$2.27 -0.08 (-3.40%)
Sector Healthcare Beta 2.52 ETF No EPS -1.47 PE 0.00
Industry Biotechnology Last Div 0 52W Range 0.76-5.85 Mkt Cap 22,027,716 Shares 9,703,840
Earning Report 05-12-21 12:30 IPO Since 2016-11-07 Exchange NASDAQ CEO Mr. Jeffrey Eisenberg
Profitability Analysis

Compound Annual Growth Rate Chart
Profit Margin Chart

TTM 2020-12-312019-12-312018-12-312017-12-31
Profitability Indicators
Revenue Per Share 0.09 0.070.01010.5
Earning Per Share -1.28 -1.73-4.48-9.66-4.98
Operating Cash Flow Per Share -0.48 -0.68-2.24-8.552.07
Free Cash Flow Per Share -0.48 -0.68-2.24-8.552.06
Book Value Per Share 1.14 1.946.0313.1119.8
Gross Profit Margin % 35.82 1000097.94
Operating Profit Margin % -667.22 -1074.41-56272.410-47.05
Tax Rate % 20.63 21.13000
Net Profit Margin % -1502.91 -2493.11-74856.590-47.4
Profitability Growth (YoY)
Revenue Growth % -2460.310-100152.83
EPS Growth % -14.73-74.99-103.0793.37
Operating Cash Flow Growth % --33.32-1-532.6-117
Free Cash Flow Growth % --33.32-1-535.3-116.87
BVPS Growth % --67.85-53.98-33.78-24.16
Compound Annual Growth Rate Chart (CAGR) 10Y CAGR 7Y CAGR 5Y CAGR 3Y CAGR
Revenue Per Share Growth % (CAGR) -NANANANA
Earning Per Share Growth % (CAGR) -NANANANA
Operating Cash Flow Per Share Growth % (CAGR) -NANANANA
Free Cash Flow Per Share Growth % (CAGR) -NANANANA
Book Value Per Share Growth % (CAGR) -NANANA-47.11
XBIO + more related news >>

29 + more related news >>